check_circleStudy Completed
Contraception
Bayer Identifier:
91458
ClinicalTrials.gov Identifier:
EudraCT Number:
Not Available
EU CT Number:
Not Available
HR-QoL and sexuality in Mirena inserted contraception users
Trial purpose
The purpose of this study is to evaluate the changes in the quality of life, as well as in the sexual activity, in women inserted with MIRENA, a hormonal contraceptive intra-uterine system, over the first 12 months of use. Patients switching from oral contraception to an intrauterine contraceptive device (here: MIRENA) will be observed in the first year post MIRENA insertion.
Key Participants Requirements
Sex
FemaleAge
18 - 35 YearsTrial summary
Enrollment Goal
141Trial Dates
November 2005 - October 2007Phase
Phase 4Could I Receive a placebo
NoProducts
Mirena (Levonorgestrel IUS, BAY86-5028)Accepts Healthy Volunteer
YesWhere to participate
Status | Institution | Location |
---|---|---|
Completed | Bordeaux, 33076, France |
Primary Outcome
- Health-related QoL scoredate_rangeTime Frame:1 yearenhanced_encryptionnoSafety Issue:
Secondary Outcome
- Sexuality Index, treatment satisfaction, usual safety outcomesdate_rangeTime Frame:1 yearenhanced_encryptionyesSafety Issue:
Trial design
Trial Type
InterventionalIntervention Type
DrugTrial Purpose
TreatmentAllocation
Non-randomizedBlinding
Open LabelAssignment
Single Group AssignmentTrial Arms
1